CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
Authors
Matthias Braun,
Amelia AguileraAshmitha Sundarrajan,
Dillon Corvino,
Kimberley Stannard,
Sophie Krumeich,
Indrajit Das,
Luize Lima,
Lizeth Guzman,
Kunlun Li,
Rui Li,
Nazhifah Salim,
Maria Jorge,
Sunyoung Ham,
Gabrielle Kelly,
Frank Vari,
Ailin Lepletier,
Ashwini Raghavendra,
Sally‐Ann Pearson,
Jason Madore,
Sébastien Jacquelin,
Maike Effern,
Brodie Quine,
Lambros Koufariotis,
Mika Casey,
Kyohei Nakamura,
Eun Seo,
Michael Hölzel,
Matthias Geyer,
Glen Kristiansen,
Touraj Taheri,
Elizabeth Ahern,
Brett Hughes,
James Wilmott,
Georgina Long,
Richard Scolyer,
Martin Batstone,
Jennifer Landsberg,
Dimo Dietrich,
Oltin Pop,
Lukas Flatz,
William Dougall,
André Veillette,
Sandra Nicholson,
Andreas Möller,
Robert Johnston,
Ludovic Martinet,
Mark Smyth,
Tobias Bald +47 authors
,
B Hughes Tip Tip